Childhood cryptosporidiosis is associated with a persistent systemic inflammatory response

Clinical Infectious Diseases

Volumn 43, Issue 5, 2006, Pages 604-608

  Kirkpatrick, B D ^a   Noel, Francine ^d   Rouzier, Patricia D ^d   Powell, Jan L ^b   Pape, J W ^d   Bois, Grylande ^d   Alston, W Kemper ^a   Larsson, Catherine J ^a   Tenney, Katherine ^a   Ventrone, Cassandra ^a   Powden, Cheryl ^a   Sreenivasan, Meera ^a   Sears, Cynthia L ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Adolescent Medicine   (Haïti)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; INTESTINE; MALE; MALNUTRITION; PRIORITY JOURNAL; STUNTING SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANTIGENS, PROTOZOAN; COHORT STUDIES; CRYPTOSPORIDIOSIS; FEMALE; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKINS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33747597319     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/506565     Document Type: Article

References (29)

1. Agnew DG, Lima AA, Newman RD, et al. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis 1998; 177:754-60.
2. Newman RD, Sears CL, Moore SR, et al. Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis 1999; 180:167-75.
3. Molbak K, Hojlyng N, Gottschau A, et al. Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa. BMJ 1993; 307:417-20.
4. Checkley W, Epstein LD, Gilman RH, Black RE, Cabrera L, Sterling CR. Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol 1998; 148:497-506.
5. Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four: seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999; 61:707-13.
6. Alcantara CS, Yang CH, Steiner TS, et al. Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am J Trop Med Hyg 2003; 68:325-8.
7. Kirkpatrick BD, Daniels MM, Jean SS, et al. Cryptosporidiosis stimulates an inflammatory intestinal response in malnourished Haitian children. J Infect Dis 2002; 186:94-101.
8. Cash R. Enteric infection. London: Chapman and Hall, 1989.
9. Delgado H, Fajardo LF, Klein R, et al. Use and interpretation of anthropmetric indicators of nutritional status. Bull World Health Org 1986; 64:929-41.
10. Redlich CA, Grauer JN, Van Bennekum AM, Clever SL, Ponn RB, Blaner WS. Characterization of carotenoid, vitamin A, and alpha-to-copheral levels in human lung tissue and pulmonary macrophages. Am J Respir Crit Care Med 1996; 154:1436-43.
11. Furr HC, Barua AB, Olson JA. Analytic methods. In: Spora MB, Roberts AB, Goodman DS, eds. The retinoids: biology, chemistry and medicine. New York: Raven Press, 1994:179-211.
12. Guerrant RL, Araujo V, Soares E, et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol 1992; 30:1238-42.
13. Gomez Morales MA, Ausiello CM, Urbani F, Pozio E. Crude extract and recombinant protein of Cryptosporidium parvum oocysts induce proliferation of human peripheral blood mononuclear cells in vitro. J Infect Dis 1995; 172:211-6.
14. Gomez Morales MA, La Rosa G, Ludovisi A, Onori AM, Pozio E. Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis. J Infect Dis 1999; 179:967-73.
15. Adjei AA, Jones JT, Riggs MW, Enriquez FJ. Evidence of thymus-independent local and systemic antibody responses to Cryptosporidium parvum infection in nude mice. Infect Immun 1999; 67:3947-51.
16. Kandil HM, Berschneider HM, Argenzio RA. Tumour necrosis factor-alpha changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut 1994; 35:934-40.
17. Laurent F, Eckmann L, Savidge TC, et al. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect Immun 1997; 65:5067-73.
18. Steiner TS, Nataro JP, Poteet-Smith CE, Smith JA, Guerrant RL. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest 2000; 105:1769-77.
19. Lacroix S, Mancassola R, Naciri M, Laurent F. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor-alpha in protection. Infect Immun 2001; 69:1635-42.
20. Seydel KB, Zhang T, Champion GA, et al. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor-alpha and interleukin-8. Infect Immun 1998; 66:2379-82.
21. Robinson P, Okhuysen PC, Chappell CL, et al. Expression of tumor necrosis factor-alpha and interleukin-1-beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms. Infect Immun 2001; 69:1172-4.
22. Ballinger AB, Camacho-Hubner C, Croft NM. Growth failure and intestinal inflammation. QJM 2001; 94:121-5.
23. Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res 2002; 58(Suppl 1):7-10.
24. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor-alpha in childhood chronic inflammatory bowel disease. Gut 1991; 32:913-7.
25. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337:1029-35.
26. Enomoto M, Pan HO, Kinoshita A, Yutani Y, Suzuki F, Takigawa M. Effects of tumor necrosis factor-alpha on proliferation and expression of differentiated phenotypes in rabbit costal chondrocytes in culture. Calcif Tissue Int 1990; 47:145-51.
27. Skerry TM. The effects of the inflammatory response on bone growth. Eur J Clin Nutr 1994; 48(Suppl 1):S190-7.
28. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319:516-8.
29. Stashenko P, Obernesser MS, Dewhirst FE. Effect of immune cytokines on bone. Immunol Invest 1989; 18:239-49.